258 related articles for article (PubMed ID: 19239912)
1. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
[TBL] [Abstract][Full Text] [Related]
2. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
3. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
5. Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
Ohkawara T; Mitsuyama K; Takeda H; Asaka M; Fujiyama Y; Nishihira J
Scand J Gastroenterol; 2008; 43(12):1497-504. PubMed ID: 18663662
[TBL] [Abstract][Full Text] [Related]
6. Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.
Balachandran S; Rodge A; Gadekar PK; Yadav VN; Kamath D; Chetrapal-Kunwar A; Bhatt P; Srinivasan S; Sharma S; Vishwakarma RA; Dagia NM
Bioorg Med Chem Lett; 2009 Aug; 19(16):4773-6. PubMed ID: 19592246
[TBL] [Abstract][Full Text] [Related]
7. A novel mTOR inhibitor is efficacious in a murine model of colitis.
Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Alam A; Pal C; Goyal M; Kundu MK; Kumar R; Iqbal MS; Dey S; Bindu S; Sarkar S; Pal U; Maiti NC; Adhikari S; Bandyopadhyay U
Bioorg Med Chem; 2011 Dec; 19(24):7365-73. PubMed ID: 22088307
[TBL] [Abstract][Full Text] [Related]
9. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation.
Fonseca LC; Dadarkar SS; Lobo AS; Suthar AC; Chauhan VS; Chandrababu S; Sharma SD; Dagia NM; Padigaru M
Eur J Pharmacol; 2010 Oct; 644(1-3):220-9. PubMed ID: 20621086
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E is a MIF Inhibitor.
Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
[TBL] [Abstract][Full Text] [Related]
11. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
[TBL] [Abstract][Full Text] [Related]
12. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
Al-Abed Y; Dabideen D; Aljabari B; Valster A; Messmer D; Ochani M; Tanovic M; Ochani K; Bacher M; Nicoletti F; Metz C; Pavlov VA; Miller EJ; Tracey KJ
J Biol Chem; 2005 Nov; 280(44):36541-4. PubMed ID: 16115897
[TBL] [Abstract][Full Text] [Related]
13. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
14. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Al-Abed Y; VanPatten S
Future Med Chem; 2011 Jan; 3(1):45-63. PubMed ID: 21428825
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
Morand EF
Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2.
Cho MK; Lee CH; Yu HS
Parasite Immunol; 2011 May; 33(5):265-75. PubMed ID: 21204854
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
19. Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice.
Ohkawara T; Nishihira J; Ishiguro Y; Otsubo E; Nagai K; Takeda H; Kato M; Yoshiki T; Iwanaga T; Asaka M
Immunol Lett; 2006 Nov; 107(2):148-54. PubMed ID: 17049622
[TBL] [Abstract][Full Text] [Related]
20. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Ohkawara T; Miyashita K; Nishihira J; Mitsuyama K; Takeda H; Kato M; Kondo N; Yamasaki Y; Sata M; Yoshiki T; Sugiyama T; Asaka M
Clin Exp Immunol; 2005 May; 140(2):241-8. PubMed ID: 15807847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
